🕵️ Contineum Therapeutics, Inc. ($CTNM)
SEC insider & ownership activity, last 12 months · CIK 1855175 · every row links its SEC filing
Over the last 12 months insiders sold $1.8M with no open-market buying against it. Daniel S. Lorrain sold $1.1M through a 10b5-1 trading plan in 19 lots (Dec–Jul). 1 planned sale is pending, the largest $432K (Daniel Lorrain). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 3 sellers, $1.8M (29 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Daniel S. Lorrain | 0 | – | 19 | $1.1M | Jul 9, 2026 |
| Watkins Tim | 0 | – | 5 | $323K | Jun 30, 2026 |
| Carmine N. Stengone | 0 | – | 5 | $320K | Jul 8, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Janus Henderson Group PLC | 7.9% | 13G | Feb 17, 2026 | filing ↗ | |
| Balyasny Asset Management L.P. | 7.4% | 13G | May 15, 2026 | filing ↗ | |
| BAM GP LLC | 7.4% | 13G | May 15, 2026 | filing ↗ | |
| Balyasny Asset Management Holdings LP | 7.4% | 13G | May 15, 2026 | filing ↗ | |
| Dames GP LLC | 7.4% | 13G | May 15, 2026 | filing ↗ | |
| Dmitry Balyasny | 7.4% | 13G | May 15, 2026 | filing ↗ | |
| Blackrock, Inc. | 6.3% | Class A | 13G | Jul 27, 2026 | filing ↗ |
| Franklin Resources, Inc. | 6.2% | 13G | Jan 29, 2026 | filing ↗ | |
| Franklin Advisers, Inc. | 6.2% | 13G | Jan 29, 2026 | filing ↗ | |
| Millennium Management LLC | exited | Class A | 13G | Jul 17, 2026 | filing ↗ |
| Millennium Group Management LLC | exited | Class A | 13G | Jul 17, 2026 | filing ↗ |
| Israel A. Englander | exited | Class A | 13G | Jul 17, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Carmine Stengone | $36K | Jul 8, 2026 | filing ↗ |
| Daniel Lorrain | $156K | Jul 1, 2026 | filing ↗ |
| Daniel Lorrain | $432K | Jun 30, 2026 | filing ↗ |
| Carmine Stengone | $150K | Jun 30, 2026 | filing ↗ |
| Timothy Watkins | $162K | Jun 30, 2026 | filing ↗ |
| Daniel Lorrain | $56K | Jun 1, 2026 | filing ↗ |
| Daniel Lorrain | $53K | May 1, 2026 | filing ↗ |
| Daniel Lorrain | $12K | Apr 6, 2026 | filing ↗ |
| Daniel Lorrain | $253K | Feb 11, 2026 | filing ↗ |
| Carmine Stengone | $118K | Feb 11, 2026 | filing ↗ |
| Daniel Lorrain | $60K | Feb 3, 2026 | filing ↗ |
| Daniel Lorrain | $47K | Jan 5, 2026 | filing ↗ |
| Timothy Watkins | $134K | Dec 29, 2025 | filing ↗ |
| Daniel Lorrain | $51K | Dec 23, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Reg FD disclosure (7.01) | Jul 13, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 13, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 26, 2026 | filing ↗ |
| Earnings (2.02) | May 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 5, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 30, 2026 | filing ↗ |
| Other events (8.01) | Apr 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 30, 2026 | filing ↗ |
| Earnings (2.02) | Mar 5, 2026 | filing ↗ |
| Other events (8.01) | Mar 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 5, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jan 23, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 23, 2026 | filing ↗ |
| Material agreement (1.01) | Dec 11, 2025 | filing ↗ |
| Other events (8.01) | Dec 11, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 11, 2025 | filing ↗ |
| Other events (8.01) | Dec 8, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 8, 2025 | filing ↗ |
| Other events (8.01) | Nov 20, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 20, 2025 | filing ↗ |
| Earnings (2.02) | Oct 30, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 30, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Sep 18, 2025 | filing ↗ |
| Other events (8.01) | Sep 18, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 18, 2025 | filing ↗ |
| Earnings (2.02) | Aug 5, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 5, 2025 | filing ↗ |